Search

everythinglearnresearchcommunity

for

Search:↓

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

CD2 might be a new treatment target for patchy alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

CS12192 effectively treats alopecia areata with better safety than current options.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

A new one-step test can quickly identify skin cancer during surgery.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Basal cell carcinomas may use IDO to protect themselves from the immune system.